BRAF and melanoma: In BRAF-mutant melanoma, BRAF inhibitors upregulate oxidative phosphorylation (OXPHOS), enhancing mitochondrial ROS accumulation and cellular susceptibility to ferroptosis (Haq et al., 2013; Schöckel et al., 2015).